References
- Snell C , KrypuyM, WongEMet al.: BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype.Breast Cancer Res.10(1) , R12 (2008).
- Flanagan JM , Munoz-AlegreM, HendersonSet al.: Gene-body methylation of ATM in peripheral blood DNA of bilateral breast cancer patients.Hum. Mol. Genet.18(7) , 1332–1342 (2006).
- Iwamoto T , YamamotoN, TaguchiT, TamakiY, NoguchiS: BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation.Breast Cancer Res. Treat. (2010) (Epub ahead of print).
- Chen Y , TolandAE, McLennanJet al.: Lack of germ-line promoter methylation in BRCA1-negative families with familial breast cancer.Genet. Test.10(4) , 281–284 (2006).
- Cho YH , YaziciH, WuHCet al.: Aberrant promoter methylation and genomic hypomethylation in tumour, adjacent normal tissues and blood from breast cancer patients.Anticancer Res.30 , 2489–2496 (2010).
- Wong EM , SoutheyMC, FoxSBet al.: Constitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation-associated pathology in early-onset breast cancer.Cancer Prev. Res. (Phila.)4 , 23–33 (2011).
- Skvortsova TE , RykovaEY, TamkovichSNet al.: Cell-free and cell-bound circulating DNA in breast tumours: DNA quantification and analysis of tumour-related gene methylation.Br. J. Cancer94 , 1492–1495 (2006).
References
- Eberth S , SchneiderB, RosenwaldAet al.: Epigenetic regulation of CD44 in Hodgkin and non-Hodgkin lymphoma.BMC Cancer10(1) , 517 (2010).
- Lou W , KrillD, DhirRet al.: Methylation of the CD44 metastasis suppressor gene in human prostate cancer.Cancer Res.59(10) , 2329–2331(1999).
- Hoebeeck J , MichelsE, PattynFet al.: Aberrant methylation of candidate tumor suppressor genes in neuroblastoma.Cancer Lett.273(2) , 336–346 (2009).
References
- Salhia B , BakerA, AhmannG, AuclairD, FonsecaR, CarptenJ: DNA methylation analysis determines the high frequency of genic hypomethylation and low frequency of hypermethylation events in plasma cell tumors.Cancer Res.70(17) , 6934–6944 (2010).
- Walker BA , WardellCP, ChiecchioLet al.: Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma.Blood117(2) , 552–562 (2011).
- Park G , KangSH, LeeJHet al.: Concurrent p16 methylation pattern as an adverse prognostic factor in multiple myeloma: a methylation-specific polymerase chain reaction study using two different primer sets.Ann. Hematol.90(1) , 73–79 (2011).